跳至主要内容
临床试验/NCT03452462
NCT03452462已完成不适用

Electrical Resynchronization and Acute Hemodynamic Effects of Direct His Bundle Pacing Compared to Biventricular Pacing

University Hospital, Geneva1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2019年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
1
主要终点
Left ventricular activation time

研究概览

简要总结

The aims are to compare Direct His Bundle Pacing (DHBP) with biventricular pacing (BiV) in terms of electrical resynchronization using electrocardiographic imaging (ECGI) and also in terms of acute hemodynamical effect using finger plethysmography and conduction velocimetry. The study will be a randomized crossover design with acute measurements.

详细描述

By recruiting native conducting tissue to relay electrical activation of the ventricles via the Purkinje fibre network, DHBP may potentially achieve greater electrical resynchronization and hemodynamic benefit compared to BiV where the electrical activation wavefronts propagate from two discrete pacing sites. Electrical synchrony achieved by these pacing modes have however never been compared. Furthermore, the acute hemodynamic effect of DHBP has been compared to BiV only in a small single study to date. The aims are to compare DHBP with BiV in terms of electrical resynchronization using electrocardiographic imaging (ECGI) and also in terms of acute hemodynamical effect using finger plethysmography and conduction velocimetry. The primary endpoint will be left ventricular activation time, with secondary endpoints including various electrical (right ventricular activation time, total ventricular activation time etc) and hemodynamic parameters (systolic pressure, cardiac output, cardiac contractility). It is expected that DHBP offers shorter left ventricular activation time (i.e. better synchrony) and hemodynamic benefit compared to BiV.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Treatment of heart failure with a standard indication for CRT (NYHA III-IV, LVEF < 35% and QRS > 130ms; or LVEF< 40% and requirement for frequent ventricular pacing, irrespective of baseline QRS duration) and optimal medical treatment.
  • •Permanent atrial fibrillation (allowing connection of the DHBP lead to the atrial port).
  • •Patients implanted with 1) a CRT pacemaker or CRT defibrillator 2) a His lead with selective or non-selective DHBP, connected to the atrial port of the generator 3) a functional right ventricular lead and 4) a functional coronary sinus lead.
  • •DHBP with selective or non-selective His capture

排除标准

  • •Age <18 years
  • •Pregnancy
  • •Inability to undergo CT or an MRI (e.g. due to severe claustrophobia)
  • •Inability or refusal to sign the patient informed consent form.

研究组 & 干预措施

Direct His Bundle Pacing

Experimental

Pacing from the His bundle lead

干预措施: Pacing (Device)

Biventricular Pacing

Active Comparator

Pacing from the right ventricular and coronary sinus leads

干预措施: Pacing (Device)

结局指标

主要结局

Left ventricular activation time

时间窗: 5 minutes

Duration of left ventricular electrical activation

次要结局

  • Right ventricular activation time(5 minutes)
  • Cardiac output(5 minutes)
  • Systolic pressure(5 minutes)
  • Total ventricular activation time(5 minutes)
  • Cardiac contractility(5 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Haran Burri, MD

Professor

University Hospital, Geneva

研究点 (1)

Loading locations...

相似试验